Chemotherapy 8 times for triple-negative breast cancer is usually commonly used drugs such as paclitaxel, doxorubicin, cyclophosphamide, epothilone, albumin paclitaxel, gemcitabine, capecitabine and so on. Triple-negative breast cancer is a special type of breast cancer, patients’ estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 indicators are all negative, the treatment methods for this type of patients mainly include surgery, radiotherapy, chemotherapy, immunotherapy, etc., and most of them are unsuitable for endocrine therapy and targeted therapy. Postoperative adjuvant chemotherapy 8 times is usually commonly used cyclophosphamide combined with epothilone chemotherapy for 4 cycles, and then sequential 4 cycles of doxorubicin chemotherapy, or 4 cycles of paclitaxel chemotherapy. In case of advanced patients chemotherapy 8 times, they can be treated with albumin paclitaxel chemotherapy alone for 8 times, or combined with gemcitabine chemotherapy for 8 times, or use capecitabine chemotherapy for 8 times, and other regimens.